Skip to Content

Workers’ Compensation Board

Search menu

Due to planned OnBoard maintenance occurring between 2:00 a.m. to 6:00 a.m. ET on Tuesday, May 21, 2024, and between 2:00 a.m. to 5:00 a.m. ET on Wednesday, May 22, 2024, email and text notifications may not be generated during this period. Please check your dashboards for prior authorization requests (PARs) and PAR responses submitted during this period. All other functionality will be working, including updates to the electronic case folders in eCase.

Save the Date – COVID-19 and Workers’ Compensation Webinar

Subject Number 046-1043 Temporary Suspension of Dr. Todd Sloan Koppel

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 201176-5W

March 21, 2018

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Todd Sloan Koppel’s authorization to treat injured workers within the New York State workers’ compensation system effective March 19, 2018. Dr. Koppel's last known business address is:

118 North Bedford Road, Suite 200
Mount Kisco, New York 10549

The Chair’s designee’s investigation has revealed that on or about March 6, 2018, Dr. Koppel was indicted by a New Jersey Grand Jury and charged with first-degree conspiracy and money laundering for allegedly submitting more than $4.4 million in fraudulent bills for service to insurance companies.

Therefore, the Chair believes that Dr. Koppel may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Koppel is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Koppel for services rendered prior to March 19, 2018 are valid but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Koppel for services rendered prior to March 19, 2018 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Clarissa M. Rodriguez